drugset / Trial / NCT02172417

Tiotropium in Combination With Concomitant Cimetidine or Ranitidine in Healthy Male and Female Subjects

NCT02172417

Phase 1 Completed 18 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Study to investigate the effect of an inhibition of the renal cationic drug transporter on single dose pharmacokinetics of intravenous tiotropium in subjects in an age close to typical Chronic Obstructive Pulmonary Disease (COPD) population

Timeline

Start
2000-07
Primary completion
2000-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cimetidine Small molecule 400 mg Oral
Subject Ranitidine Unknown 300 mg Oral
Subject Tiotropium Other / unclassified 14.4 ug Intravenous

Indications

No indication recorded.